Trial Profile
Post-marketing Carcinogenicity Study of Bupropion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Antidepressants; Serotonin uptake inhibitors; Tricyclic antidepressants
- Indications Depressive disorders
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 09 Feb 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 09 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Mar 2010 New trial record